Michael A. Metzger, President and COO at Syndax Pharmaceuticals Inc (SNDX), sold 122,000 shares at $19.20 ($2.3M) on 2021-10-26, disclosed to the SEC on 2021-10-27.
Open-market sale of $2.3M SNDX by President and COO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.13 | 44,704 | $855K | 36.6% |
| 2 | $19.13 | 44,704 | $855K | 36.6% |
| 3 | $19.20 | 16,296 | $313K | 13.4% |
| 4 | $19.20 | 16,296 | $313K | 13.4% |
| Total | $19.15 avg | 122,000 | $2.3M | 100% |
| Filing → |
| SNDX | SELL | 2026-02-10 | $361K | — | Filing → |
| SNDX | SELL | 2026-02-06 | $153K | — | Filing → |
| SNDX | SELL | 2025-09-08 | $5.2M | — | Filing → |